How Jennifer Lalama’s FDA Findings Are Shaping Compliance in 2025
In 2025, the importance of FDA inspections has reached a pivotal moment for the pharmaceutical and MedTech industries. Regulatory scrutiny has never been more intense, and compliance failures can result in significant setbacks for companies striving to meet stringent requirements. With heightened oversight, businesses are increasingly looking to improve their regulatory strategies to avoid costly…